UV Flu Technologies (UVFT) Stock Price
UV Flu Technologies Price
Revenue has compounded at 36.4% per year over the past 7 years to 175,500.00 USD. UV Flu Technologies's net margin stands at -539.4%, up from -545.4% several years earlier. The stock trades about 3,100% above its 52-week low.
UV Flu Technologies stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of UV Flu Technologies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how UV Flu Technologies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing UV Flu Technologies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | UV Flu Technologies Price |
|---|---|
| 8/10/2026 | 0.00 USD |
| 8/7/2026 | 0.00 USD |
| 8/6/2026 | 0.00 USD |
| 8/5/2026 | 0.00 USD |
| 8/4/2026 | 0.00 USD |
| 8/3/2026 | 0.00 USD |
| 7/30/2026 | 0.00 USD |
| 7/29/2026 | 0.00 USD |
| 7/28/2026 | 0.00 USD |
| 7/27/2026 | 0.00 USD |
| 7/24/2026 | 0.00 USD |
| 7/23/2026 | 0.00 USD |
| 7/22/2026 | 0.00 USD |
| 7/21/2026 | 0.00 USD |
| 7/20/2026 | 0.00 USD |
| 7/17/2026 | 0.00 USD |
| 7/16/2026 | 0.00 USD |
| 7/15/2026 | 0.00 USD |
| 7/14/2026 | 0.00 USD |
| 7/13/2026 | 0.00 USD |
| 7/10/2026 | 0.00 USD |
| 7/9/2026 | 0.00 USD |
| 7/8/2026 | 0.00 USD |
| 7/7/2026 | 0.00 USD |
| 7/6/2026 | 0.00 USD |
| 7/2/2026 | 0.00 USD |
| 7/1/2026 | 0.00 USD |
| 6/30/2026 | 0.00 USD |
| 6/29/2026 | 0.00 USD |
| 6/26/2026 | 0.01 USD |
| 6/25/2026 | 0.01 USD |
| 6/24/2026 | 0.01 USD |
| 6/23/2026 | 0.01 USD |
| 6/22/2026 | 0.01 USD |
| 6/19/2026 | 0.00 USD |
| 6/18/2026 | 0.00 USD |
| 6/17/2026 | 0.00 USD |
| 6/16/2026 | 0.00 USD |
| 6/15/2026 | 0.00 USD |
| 6/12/2026 | 0.00 USD |
| 6/11/2026 | 0.00 USD |
| 6/10/2026 | 0.00 USD |
| 6/9/2026 | 0.00 USD |
| 6/8/2026 | 0.00 USD |
| 6/5/2026 | 0.00 USD |
| 6/4/2026 | 0.00 USD |
| 6/3/2026 | 0.00 USD |
| 6/2/2026 | 0.00 USD |
| 6/1/2026 | 0.00 USD |
| 5/29/2026 | 0.00 USD |
| 5/28/2026 | 0.00 USD |
| 5/27/2026 | 0.00 USD |
| 5/26/2026 | 0.00 USD |
| 5/22/2026 | 0.00 USD |
| 5/21/2026 | 0.00 USD |
| 5/20/2026 | 0.00 USD |
| 5/19/2026 | 0.00 USD |
| 5/18/2026 | 0.00 USD |
| 5/15/2026 | 0.00 USD |
| 5/14/2026 | 0.00 USD |
| 5/13/2026 | 0.00 USD |
| 5/12/2026 | 0.00 USD |
| 5/11/2026 | 0.00 USD |
| 5/8/2026 | 0.00 USD |
| 5/7/2026 | 0.00 USD |
| 5/6/2026 | 0.00 USD |
| 5/5/2026 | 0.00 USD |
| 5/4/2026 | 0.00 USD |
| 5/1/2026 | 0.00 USD |
| 4/30/2026 | 0.00 USD |
| 4/29/2026 | 0.00 USD |
| 4/28/2026 | 0.00 USD |
| 4/27/2026 | 0.00 USD |
| 4/24/2026 | 0.00 USD |
| 4/23/2026 | 0.00 USD |
| 4/22/2026 | 0.00 USD |
| 4/21/2026 | 0.00 USD |
| 4/20/2026 | 0.00 USD |
| 4/17/2026 | 0.00 USD |
| 4/16/2026 | 0.00 USD |
| 4/15/2026 | 0.00 USD |
| 4/14/2026 | 0.00 USD |
| 4/13/2026 | 0.00 USD |
| 4/10/2026 | 0.00 USD |
| 4/9/2026 | 0.00 USD |
| 4/8/2026 | 0.00 USD |
| 4/7/2026 | 0.00 USD |
| 4/6/2026 | 0.00 USD |
| 4/2/2026 | 0.00 USD |
| 4/1/2026 | 0.00 USD |
| 3/31/2026 | 0.00 USD |
| 3/30/2026 | 0.00 USD |
| 3/27/2026 | 0.00 USD |
| 3/26/2026 | 0.00 USD |
| 3/25/2026 | 0.00 USD |
| 3/24/2026 | 0.00 USD |
| 3/23/2026 | 0.00 USD |
| 3/20/2026 | 0.00 USD |
| 3/19/2026 | 0.00 USD |
| 3/18/2026 | 0.00 USD |
| 3/17/2026 | 0.00 USD |
| 3/16/2026 | 0.00 USD |
| 3/13/2026 | 0.00 USD |
| 3/12/2026 | 0.00 USD |
| 3/11/2026 | 0.00 USD |
| 3/10/2026 | 0.00 USD |
| 3/9/2026 | 0.00 USD |
| 3/6/2026 | 0.00 USD |
| 3/5/2026 | 0.00 USD |
| 3/4/2026 | 0.00 USD |
| 3/3/2026 | 0.00 USD |
| 3/2/2026 | 0.00 USD |
| 2/27/2026 | 0.00 USD |
| 2/26/2026 | 0.00 USD |
| 2/25/2026 | 0.00 USD |
| 2/24/2026 | 0.00 USD |
| 2/23/2026 | 0.00 USD |
| 2/20/2026 | 0.00 USD |
| 2/19/2026 | 0.00 USD |
| 2/18/2026 | 0.00 USD |
| 2/17/2026 | 0.00 USD |
| 2/13/2026 | 0.00 USD |
| 2/12/2026 | 0.00 USD |
| 2/11/2026 | 0.00 USD |
| 2/10/2026 | 0.00 USD |
| 2/9/2026 | 0.00 USD |
| 2/6/2026 | 0.00 USD |
| 2/5/2026 | 0.00 USD |
| 2/4/2026 | 0.00 USD |
| 2/3/2026 | 0.00 USD |
| 2/2/2026 | 0.00 USD |
| 1/30/2026 | 0.00 USD |
| 1/29/2026 | 0.00 USD |
| 1/28/2026 | 0.00 USD |
| 1/27/2026 | 0.00 USD |
| 1/26/2026 | 0.00 USD |
| 1/23/2026 | 0.00 USD |
| 1/22/2026 | 0.00 USD |
| 1/21/2026 | 0.00 USD |
| 1/20/2026 | 0.00 USD |
| 1/16/2026 | 0.00 USD |
| 1/15/2026 | 0.00 USD |
| 1/14/2026 | 0.00 USD |
| 1/13/2026 | 0.00 USD |
| 1/12/2026 | 0.00 USD |
| 1/9/2026 | 0.00 USD |
| 1/8/2026 | 0.00 USD |
| 1/7/2026 | 0.00 USD |
| 1/6/2026 | 0.00 USD |
| 1/5/2026 | 0.00 USD |
| 1/2/2026 | 0.00 USD |
| 12/31/2025 | 0.00 USD |
| 12/30/2025 | 0.00 USD |
| 12/29/2025 | 0.00 USD |
| 12/26/2025 | 0.00 USD |
| 12/24/2025 | 0.00 USD |
| 12/23/2025 | 0.00 USD |
| 12/22/2025 | 0.00 USD |
| 12/19/2025 | 0.00 USD |
| 12/18/2025 | 0.00 USD |
| 12/17/2025 | 0.00 USD |
| 12/16/2025 | 0.00 USD |
| 12/15/2025 | 0.00 USD |
| 12/12/2025 | 0.00 USD |
| 12/11/2025 | 0.00 USD |
| 12/10/2025 | 0.00 USD |
| 12/9/2025 | 0.00 USD |
| 12/8/2025 | 0.00 USD |
| 12/5/2025 | 0.00 USD |
| 12/4/2025 | 0.00 USD |
| 12/3/2025 | 0.00 USD |
| 12/2/2025 | 0.00 USD |
| 12/1/2025 | 0.00 USD |
| 11/28/2025 | 0.00 USD |
| 11/26/2025 | 0.00 USD |
| 11/25/2025 | 0.00 USD |
| 11/24/2025 | 0.00 USD |
| 11/21/2025 | 0.00 USD |
| 11/20/2025 | 0.00 USD |
| 11/19/2025 | 0.00 USD |
| 11/18/2025 | 0.00 USD |
| 11/17/2025 | 0.00 USD |
| 11/14/2025 | 0.00 USD |
| 11/13/2025 | 0.00 USD |
| 11/12/2025 | 0.00 USD |
| 11/11/2025 | 0.00 USD |
| 11/10/2025 | 0.00 USD |
| 11/7/2025 | 0.00 USD |
| 11/6/2025 | 0.00 USD |
| 11/5/2025 | 0.00 USD |
| 11/4/2025 | 0.00 USD |
| 11/3/2025 | 0.00 USD |
| 10/31/2025 | 0.00 USD |
| 10/30/2025 | 0.00 USD |
| 10/29/2025 | 0.00 USD |
| 10/28/2025 | 0.00 USD |
| 10/27/2025 | 0.00 USD |
| 10/24/2025 | 0.00 USD |
| 10/23/2025 | 0.00 USD |
| 10/22/2025 | 0.00 USD |
| 10/21/2025 | 0.00 USD |
| 10/20/2025 | 0.00 USD |
| 10/17/2025 | 0.00 USD |
| 10/16/2025 | 0.00 USD |
| 10/15/2025 | 0.00 USD |
| 10/14/2025 | 0.00 USD |
| 10/13/2025 | 0.00 USD |
| 10/10/2025 | 0.00 USD |
| 10/9/2025 | 0.00 USD |
| 10/8/2025 | 0.00 USD |
| 10/7/2025 | 0.00 USD |
| 10/6/2025 | 0.00 USD |
| 10/3/2025 | 0.00 USD |
| 10/2/2025 | 0.00 USD |
| 10/1/2025 | 0.00 USD |
| 9/30/2025 | 0.00 USD |
| 9/29/2025 | 0.00 USD |
| 9/26/2025 | 0.00 USD |
| 9/25/2025 | 0.00 USD |
| 9/24/2025 | 0.00 USD |
| 9/23/2025 | 0.00 USD |
| 9/22/2025 | 0.00 USD |
| 9/19/2025 | 0.00 USD |
| 9/18/2025 | 0.00 USD |
| 9/17/2025 | 0.00 USD |
| 9/16/2025 | 0.00 USD |
| 9/15/2025 | 0.00 USD |
| 9/12/2025 | 0.00 USD |
| 9/11/2025 | 0.00 USD |
| 9/10/2025 | 0.00 USD |
| 9/9/2025 | 0.00 USD |
| 9/8/2025 | 0.00 USD |
| 9/5/2025 | 0.00 USD |
| 9/4/2025 | 0.00 USD |
| 9/3/2025 | 0.00 USD |
| 9/2/2025 | 0.00 USD |
| 8/29/2025 | 0.00 USD |
| 8/28/2025 | 0.00 USD |
| 8/27/2025 | 0.00 USD |
| 8/26/2025 | 0.00 USD |
| 8/25/2025 | 0.00 USD |
| 8/22/2025 | 0.00 USD |
| 8/21/2025 | 0.00 USD |
| 8/20/2025 | 0.00 USD |
| 8/19/2025 | 0.00 USD |
| 8/18/2025 | 0.00 USD |
| 8/15/2025 | 0.00 USD |
| 8/14/2025 | 0.00 USD |
| 8/13/2025 | 0.00 USD |
UV Flu Technologies Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
UV Flu Technologies Income Statement, Balance Sheet, Cash Flow Statement
| EBITk USD |
|---|
| SHARESM |
| 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -1,000.00 | – |
| 12.43 | 28.25 | 35.52 | 35.52 | 11.40 | 14.54 | 38.50 | 56.26 | 69.33 | 81.95 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales UV Flu Technologies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue UV Flu Technologies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare UV Flu Technologies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares UV Flu Technologies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against UV Flu Technologies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
UV Flu Technologies stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
UV Flu Technologies Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
UV Flu Technologies business model & stock analysis
UV Flu Technologies SWOT Analysis
Strengths
Advanced Technology: UV Flu Technologies Inc possesses advanced technology that enables the development of innovative products in the field of air purification.
Patented Solutions: The company holds patents for its unique UV-based air disinfection systems, providing a competitive advantage in the market.
Strong Research and Development: UV Flu Technologies Inc emphasizes continuous research and development activities, allowing for the creation of cutting-edge air purification solutions.
Weaknesses
Limited Market Presence: Despite its technological prowess, UV Flu Technologies Inc faces challenges in expanding its market share due to limited brand recognition and distribution channels.
High Production Costs: The cost of manufacturing UV-based air disinfection systems can be relatively high, potentially impacting profit margins and pricing competitiveness.
Dependence on Economic Conditions: UV Flu Technologies Inc's revenue and growth prospects are influenced by overall economic conditions and consumer spending patterns.
Opportunities
Increasing Demand for Air Purification: The growing awareness and concern for air quality among both residential and commercial customers create opportunities for UV Flu Technologies Inc to tap into a rapidly expanding market.
Emerging Markets: Expansion into emerging markets, where the need for air purification solutions is rising, presents untapped growth potential for UV Flu Technologies Inc.
Partnerships and Collaborations: Forming strategic partnerships with other industry players or organizations focused on environmental health could enhance product development, market reach, and overall competitiveness.
Threats
Intense Competition: UV Flu Technologies Inc faces competition from established air purification companies and potential new entrants in the market.
Regulatory Environment: Changing regulations and compliance requirements related to air quality standards may impact the company's product development and market access.
Technological Advancements: Rapid advancements in air purification technologies could challenge the uniqueness and competitive edge of UV Flu Technologies Inc's products.
UV Flu Technologies Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
UV Flu Technologies historical P/E ratio, EBIT multiple, and P/S ratio
UV Flu Technologies annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
UV Flu Technologies shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
UV Flu Technologies stock splits
UV Flu Technologies shareholder structure
| % | Name |
|---|---|
0.00000% |
UV Flu Technologies Executives and Management Board
4 members · avg. age 58 · 0 % women
Mr. Michael Ross (63)
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Director · since 2013
150,000.00 USD
Dr. Jerrold Leikin (61)
Independent Director
Mr. Thomas Mahowald (60)
Independent Director
Mr. Jeremy Noonan (48)
Independent Director
Frequently asked questions about UV Flu Technologies
The business model of UV Flu Technologies Inc revolves around providing air purification solutions. The company specializes in developing advanced technologies that mitigate the spread of airborne pathogens and contaminants. UV Flu Technologies Inc is dedicated to creating and manufacturing cutting-edge ultraviolet germicidal irradiation (UVGI) systems, which sterilize the air by significantly reducing the presence of bacteria, viruses, and other harmful microorganisms. Through their innovative products, UV Flu Technologies Inc aims to enhance indoor air quality in various settings, including residential, commercial, and healthcare environments.
UV Flu Technologies Inc is primarily active in the air purification industry. Using advanced ultraviolet germicidal irradiation technology, the company specializes in manufacturing and selling products that eliminate harmful microorganisms in the air. UV Flu Technologies Inc's solutions are widely used in various sectors such as healthcare, hospitality, commercial, residential, and industrial settings. With a strong focus on providing cleaner and healthier environments, UV Flu Technologies Inc has carved a niche for itself in the air purification industry.
The main competitors of UV Flu Technologies Inc in the market include companies such as 3M Company, Honeywell International Inc, and Philips Lighting Holding B.V.
UV Flu Technologies Inc is a company that specializes in the development and distribution of advanced ultraviolet technologies designed to eradicate airborne pathogens and contaminants. Founded in 2006, UV Flu Technologies has been dedicated to providing innovative solutions to combat the spread of infectious diseases. The company's cutting-edge technologies leverage the power of ultraviolet light to neutralize harmful viruses, bacteria, and mold, ensuring cleaner and healthier indoor environments. With a strong focus on research and development, UV Flu Technologies continues to enhance its product offerings, contributing to the improvement of indoor air quality worldwide.
UV Flu Technologies Inc has achieved several significant milestones in its journey. Some notable achievements include the development and patenting of the innovative ViraTech UV-400 air purification technology. This breakthrough technology has garnered recognition from leading experts in the field and has been proven effective in eliminating airborne allergens, germs, and viruses, including the flu virus. The company has also successfully forged strategic partnerships and collaborations, enhancing its market reach and global presence. UV Flu Technologies Inc continues to make advancements in air purification solutions, ensuring healthier environments for individuals and communities worldwide.
UV Flu Technologies Inc is primarily present in various countries and regions worldwide. The company has a global presence, with its products and services being utilized in numerous markets. Some of the key regions where UV Flu Technologies Inc operates include North America, Europe, Asia-Pacific, Latin America, and the Middle East. Through its distribution networks and strategic partnerships, UV Flu Technologies Inc is able to cater to customers and stakeholders across different geographical locations.
UV Flu Technologies Inc represents a strong commitment to providing innovative solutions for air purification and disinfection. The company aims to improve the quality of indoor air by utilizing ultraviolet (UV) light technology in their products. With a focus on health and wellness, UV Flu Technologies Inc strives to create a safer and healthier environment for individuals. Their corporate philosophy centers around the belief that clean air is vital for well-being and that their cutting-edge technologies can effectively eliminate harmful contaminants. By continuously pushing boundaries and delivering high-quality products, UV Flu Technologies Inc remains dedicated to promoting a healthier lifestyle through advanced air purification solutions.
Converted at the current exchange rate, the UV Flu Technologies share trades at 0.00 EUR (0.00 USD).
UV Flu Technologies Inc offers products and services in the field of indoor air purification. The company aims to create cleaner and healthier air in residential and work environments through the use of state-of-the-art technology. The goal is to particularly eliminate germs, mold, bacteria, and viruses from the indoor air. The products offered include the UV2000S, an air purifier for use in private households, schools, universities, hospitals, restaurants, or offices. The air purifier disinfects the indoor air through a combination of ultraviolet (UV) light and filter technology to reduce germs, bacteria, viruses, and other pollutants in the vicinity of the device. The UV2000S is also designed to remove odors, mold, and dust mites from the indoor air. The device operates extremely quietly and is invisible to the user. In addition to the UV2000S, UV Flu Technologies also offers the UV400, a device for commercial air purification. The device is suitable for large rooms and is capable of reducing bacteria, viruses, mold spores, and other fine particulate matter in the air. The UV400 also utilizes a combination of UV light and filter technology. It is highly energy-efficient, has low operating and maintenance costs, and an exceptionally long lifespan. UV Flu Technologies also provides a UV-C lamp for use in heating and air conditioning systems, which disinfects bacteria and viruses in the air and is crucial for the efficient operation of air conditioning systems. In addition to the products, UV Flu Technologies also offers services such as air quality analysis and consulting to ensure clean and healthy indoor air. The air quality analysis is conducted with state-of-the-art instruments to determine if there are particles, mold, or other pollutants in the air. Consultation with recommendations for improving air quality, focusing on relevant safety and health standards, is a significant added value of the company. The business model is based on the sale of products that can be used in homes or commercial environments, as well as services to support and advise customers. The company also conducts research and development to continuously improve air purification technology. Through marketing and sales efforts, a broad target audience is reached to raise awareness of UV Flu Technologies' products and services. Overall, this business model enables the realization of high quality indoor air and makes an important contribution to a healthy environment.
The revenue cannot currently be calculated for UV Flu Technologies.
The profit cannot currently be calculated for UV Flu Technologies.
The P/E ratio cannot be calculated for UV Flu Technologies at the moment.
The P/S cannot be calculated for UV Flu Technologies currently.
The Eulerpool Quality Score for UV Flu Technologies is 2/10.
The ISIN of UV Flu Technologies is US9180992011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of UV Flu Technologies is UVFT. The ticker symbol is used to trade UV Flu Technologies shares on the stock exchange.
UV Flu Technologies paid dividends every year for the past 0 years.
UV Flu Technologies is assigned to the '—' sector.
The dividends of UV Flu Technologies are distributed in USD.
UV Flu Technologies stock
UV Flu Technologies Peer Group
UV Flu Technologies FIGI
All fundamentals and in-depth analysis of UV Flu Technologies
Our stock analysis for UV Flu Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of UV Flu Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.